Picture of Esperion Therapeutics logo

ESPR — Esperion Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapValue Trap

Brief: Esperion Therapeutics Q3 Basic EPS USD -0.15

Nov 07 (Reuters) - Esperion Therapeutics Q3 product sales USD 31.106 million.
* Q3 operating expenses USD 67.658 million
* Q3 operating income USD -16.026 million
* Q3 net income USD -29.524 million

Recent news on Esperion Therapeutics

See all news